Induction of the urokinase plasminogen activator system by oncostatin M promotes endothelial migration

Journal of Cellular Biochemistry

Volumn 79, Issue 2, 2000, Pages 239-248

  Strand, Kurt ^a   Murray, Jacqueline ^a   Aziz, Salim ^b   Ishida, Atsushi ^a   Rahman, Salman ^c   Patel, Yatin ^c   Cardona, Carlos ^a   Hammond, William P ^a   Savidge, Geoffrey ^c   Wijelath, Errol S ^a,d  

^a St John Providence Health System   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d HOPE HEART INSTITUTE   (United States)

Author keywords

Angiogenesis; Cytokine; Inflammation; Macrophages; Proteolysis

Indexed keywords

CYTOKINE; MESSENGER RNA; ONCOSTATIN M; PLASMIN; PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; RNA ANALYSIS;

CELLS, CULTURED; CHEMOTAXIS; ENDOTHELIUM, VASCULAR; HUMAN; HYDROLYSIS; PEPTIDES; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033805794     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4644(20001101)79:2<239::AID-JCB70>3.0.CO;2-2     Document Type: Article

References (45)

1. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
2. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells
3. Neuropoietic cytokines in the hematopoietic fold
4. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells
5. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice
6. Physiological consequences of loss of plasminogen activator gene function in mice
7. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
8. Role of macrophages in would healing
9. Urokinase-urokinase receptor interaction: Non-mitogenic signal transduction in human epidermal cells
10. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells
11. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes
12. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
13. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells
14. Angiogenesis
15. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor
16. The urokinase receptor is required for human monocyte chemotaxis in vitro
17. Binding of plasminogen to cultured human endothelial cells
18. Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts
19. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase
20. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells
21. The urokinase receptor is a major vitronectinbinding protein on endothelial cells
22. Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms
23. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor
24. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity
25. Leukaemia inhibitory factor and oncostatin M modulate expression of urokinase plasminogen activator and fibrinogen
26. Transforming growth factor-beta 1 modulates basic fibrobiast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro
27. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
28. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis
29. Upregulation of urokinase receptor expression on migrating endothelial cells
30. Cyclooxygenase-2 activity is necessary for the angiogenic properties of oncostatin M
31. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
32. Vasculogenesis
33. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6
34. Pieces of eight: Bioactive fragments of extracellular proteins as regulators of angiogenesis
35. Cell-associated plasminogen activation: Regulation and physiological functions
36. Cell adhesion and angiogenesis
37. The plasminogen activator/plasmin system
38. Oncostatin M induces angiogenesis in vitro and in vivo
39. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy
40. Regulation of integrin function by the urokinase receptor
41. Identification of the urokinase receptor as an adhesion receptor for vitronectin
42. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spin-dle morphology
43. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration
44. Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells